Obesity & Diabetes Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity & Diabetes Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Hypertension Therapy
Olmesartan medoxomil effective for hypertension treatment in diabetes
May 31st, 2004
Olmesartan medoxomil in combination with hydrochlorothiazide is effective at controlling blood pressure in diabetic patients with hypertension. "Angiotensin receptor blockers (ARBs) are highly effective antihypertensive agents with excellent safety profiles. ARBs have been shown to improve cardiovascular morbidity and mortality in hypertensive patients with heart failure or diabetic nephropathy. For this later class of patients, the American Diabetes Association recommends ARBs as the primary treatment option," investigators in the United States report. "The ARBs function by blocking the binding of angiotensin-II (A-II) to its receptor, thereby...
Source: Obesity & Diabetes Week (2004-05-31)
|
